Injective Files for SEC Transfer Agent Status to Move Securities Records Onchain

INJ News

Injective (INJ), the finance-focused layer-1 altcoin, said it has filed a transfer agent registration with the US Securities and Exchange Commission, aiming to bring securities ownership records directly onchain. A transfer agent is the institution that maintains a company's official shareholder ledger and updates ownership each time a security changes hands — work today handled off-chain across multiple intermediaries. By running that function on its network, Injective argues token holders could hold legal title without post-trade reconciliation, settling in under a second. The move would push the Injective ecosystem beyond tokenization infrastructure and into the regulated core of who legally owns a security.

Alongside the filing, Injective published a whitepaper aligned with the European Union's Markets in Crypto-Assets framework, or MiCA, the bloc's comprehensive rulebook for digital-asset issuers and service providers. The document is designed to let the protocol roll out compliance-ready services across EU member states, and the team framed it as a signal of institutional confidence in the network. Pairing a US regulatory filing with an EU-facing disclosure on the same day underscores Injective's push to position itself as a dual-jurisdiction venue for tokenized real-world assets. The company said the two moves together broaden the regulated pathways available to issuers building on its rails.

The disclosures came as part of the Injective Summit, the protocol's own event, where the team said further announcements are still to come. Injective has built its roadmap around the issuance and trading of tokenized securities and real-world assets, leaning on sub-second block times and on-chain automated market maker and order-book modules aimed at institutional users. Positioning the transfer agent bid as a summit centerpiece signals the team wants regulated ownership records to anchor its next growth phase. Management indicated the filing is one step in a broader sequence of product and compliance releases planned around the gathering rather than a standalone announcement.

One caveat tempers the news: Injective has not identified the legal entity that submitted the application, nor has it released a public SEC filing that would let outside parties confirm the registration. That leaves the claim, announced through the company's own channels, unverified against the regulator's EDGAR system as of publication. Transfer agent registrations are reviewed by the SEC before they take effect, so approval is not guaranteed and timing remains open. Readers should treat the filing as a stated company action rather than a completed regulatory milestone until a matching public record appears. We flag the gap because the distinction is material for anyone modeling the outcome.

Injective's filing lands amid a broader Wall Street move to rebuild market plumbing on blockchains. Nasdaq has been among the most active: last month it partnered with on-chain data network Pyth to pipe its proprietary TotalView market data to blockchain applications, and earlier this year it worked with Kraken and tokenization firm Backed on infrastructure linking traditional equities to public networks. The parallel effort shows incumbents are not only tokenizing assets but also targeting market-data distribution, issuance and settlement. Against that backdrop, Injective is betting a purpose-built layer-1 can compete with exchanges retrofitting legacy systems for on-chain, round-the-clock trading.

The institutional race extends further. Intercontinental Exchange, parent of the New York Stock Exchange, has widened its tokenization strategy through a partnership with Securitize to develop infrastructure for on-chain stocks and exchange-traded funds built for 24/7 trading and instant settlement. Meanwhile the Depository Trust & Clearing Corporation, the main post-trade utility for US securities markets, is preparing to launch a tokenized Collateral AppChain to automate collateral management and settlement. These moves crowd the same lane Injective is chasing, yet they also validate its thesis that legacy post-trade systems are ripe for on-chain replacement — turning the transfer agent bid into a claim on a fast-growing market.

On our reading, COINOTAG's proprietary 42-indicator composite S/R scoring engine rates the $5.07 resistance at 80/100 — the strongest overhead level — driven by the confluence of the volume Point of Control and a prior swing high, with the $4.88 barrier scored 59/100 off the Value Area High and EMA 50. Nearby support at $4.58 carries a 73/100 score from the Donchian and Bollinger lower bands. INJ trades near $4.84, down 5.35% on the day, with RSI at 49.61 and a bullish MACD in an otherwise sideways trend. Derivatives skew cautious: funding is slightly negative at -0.0091% and open interest a thin $14.97 million, while a 25/100 bear-market Fear & Greed reading confirms extreme fear. A daily close above $5.07 would open the $5.34 zone; losing $4.58 invalidates the bullish case.